Public companies disclose large amounts of information about how they operate, finance themselves, and report results. Much of this information appears outside the headline financial statements–in footnotes, governance disclosures, and narrative discussion in company filings.
At Hudson Labs, we sort disclosures into categories that capture recurring patterns in corporate reporting, focusing on areas where governance, reporting, or financial risk have a demonstrable and tested association with adverse events.
The Co-Analyst reviews disclosures within each category to evaluate the reporting environment they represent and assigns a rating. The risk ratings in these categories feeds into the forensic risk score model.
The categories below describe recurring patterns in corporate disclosures that often signal areas of heightened reporting or governance risk. For each category, we highlight a well-known historical case where similar signals appeared before broader problems became visible to the market.
Summary
The table below summarizes the disclosure categories used in our framework.
Earnings and Accounting
What this captures
This category looks at how reported earnings, margins, and growth are produced, not just what the final numbers are. It focuses on accounting choices, estimates, classifications, and timing decisions that can materially shape reported performance.
That includes things like revenue recognition, reserve releases, capitalization policies, impairment judgments, acquisition accounting, fair value adjustments, non-GAAP exclusions, and other reporting mechanics that affect when income or expense is recognized and how comparable results are from one period to the next.
Typical signals:
- Extensive use of non-GAAP metrics or adjusted earnings measures
- Frequent changes in reporting structure, core KPis, estimates, or accounting policies.
- Significant reliance on accounting estimates or valuation assumptions
- Revenue recognition policies that depend heavily on judgment or timing
- Capitalization of costs that would normally be expensed (e.g., development, customer acquisition, or software costs)
- Reserve releases or changes in provisioning assumptions that boost reported earnings
- Acquisition accounting adjustments that materially affect reported earnings or margins
- Classification shifts between operating and non-operating items
- Frequent impairments, reserve adjustments, or restructuring charges
- Large differences between reported earnings and underlying cash generation
Why this matters
Not all earnings are created the same way. Two companies can report similar growth or margins, but one may be getting there through straightforward operating performance while the other relies more heavily on accounting judgments, timing shifts, or presentation choices.
These mechanics are often legitimate, but they can still make results harder to interpret. When reported performance depends heavily on discretionary accounting decisions, investors may get a less clear view of the underlying business. The Co-Analyst highlights cases where accounting treatment plays an unusually important role in shaping the numbers investors see.
Example
Valeant Pharmaceuticals (now known as Bausch Health Companies Inc.)
2010 – 2015: Under CEO Michael Pearson, Valeant pursues an aggressive acquisition strategy while reporting strong adjusted earnings that exclude acquisition costs, restructuring charges, and other expenses.
2014 – 2015: Non-GAAP metrics such as “cash EPS” become central to the company’s performance narrative, excluding recurring costs including stock-based compensation and acquisition-related expenses.
October 2015: A report from short seller Citron Research raises questions about Valeant’s relationship with specialty pharmacy Philidor Rx Services, prompting broader scrutiny of the company’s accounting and business model.
Late 2015–2016: Regulators and Congress begin investigations into Valeant’s accounting and disclosures as concerns about its earnings quality intensify.
2016: Valeant restates financial statements related to revenue recognition for sales to Philidor.
Liquidity, Credit & Financing Structure
What this captures
This category looks at whether a company’s liquidity and funding position is straightforward and supported by operating cash flow, or whether it relies on fragile funding, heavy refinancing, or financial structures that can make cash flow, leverage, or risk harder to interpret. It covers classic liquidity signals (cash burn, revolvers, covenants, near-term maturities) as well as “engineered” financing like receivables factoring, securitisations, supply-chain finance, sale-leasebacks, guarantees, and other off-balance-sheet arrangements that shift or obscure economic risk.
Typical disclosure signals
- Heavy reliance on short-term borrowing or revolving credit facilities
- Disclosures around covenant constraints or refinancing needs
- Use of supplier finance, receivables factoring, or securitization programs
- Sale-leasebacks or off-balance-sheet financing structures
- Funding models dependent on continuous access to capital markets
Why this matters
Liquidity is where problems become non-optional. Companies with weak cash generation or tight funding can be forced into value-destructive actions – dilutive raises, expensive debt, asset sales, or covenant-driven behavior – often at the worst time. Structural financing can be perfectly legitimate, but it can also mask underlying cash weakness, pull future cash forward, or move leverage and obligations out of view, making a business look healthier than it is. When funding is opaque, short-term, or heavily engineered, small shocks can turn into sudden crises, and investors are usually the last to find out.
Example
Enron (1999–2001)
1999: Enron establishes off-balance-sheet special purpose entities, including the LJM partnerships, to conduct hedging and financing transactions tied to the company’s assets.
1999 – 2000: These entities engage in billions of dollars of transactions with Enron, allowing the company to move debt and losses off its balance sheet while maintaining reported leverage and liquidity.
2000 – 2001: Enron continues relying on structured financing arrangements and related entities to support its reported financial position.
October 2001: Enron announces a roughly $1 billion reduction in shareholder equity tied to transactions with the off-balance-sheet partnerships.
October – November 2001: As investors and counterparties reassess Enron’s financial structure, confidence deteriorates and liquidity evaporates.
December 2001: Enron files for bankruptcy after losing access to financing markets.
Related-Party Relationships
What this captures
This category focuses on situations where a company conducts business with insiders, affiliates, or insider-linked entities. These relationships can include transactions with executives, directors, family members, or companies they control, as well as arrangements where the company is financially supporting or otherwise economically tied to a counterparty connected to management.
The goal is to identify cases where key parts of the business – such as revenue, suppliers, financing, or strategic partnerships – are connected to insiders or affiliated entities in ways that may not be fully arm’s-length.
Why this matters
Related-party relationships can create conflicts of interest between management and outside shareholders. When insiders or their affiliates sit on both sides of meaningful transactions, the normal discipline of independent negotiations can weaken.
These arrangements can create opportunities for earnings management, e.g. profit shifting or other transaction structures that make it harder for investors to fully understand how value is moving within the business. In some cases, heavy reliance on insider-linked counterparties can also create operational dependence or reduce transparency into how the business is really performing.
Examples
Super Micro Computer (2018 – present)
2019: Hudson Labs’ forensic risk score first flagged elevated financial-reporting risk signals for SMCI based on disclosures in its filings.
2022: Hudson Labs’ AI specifically identified related-party transactions involving supplier relationships linked to company insiders, placing SMCI among firms with the highest related-party risk in disclosure data.
2023: SMCI’s stock surges during the AI-server boom even as these related-party risks remain visible in filings but largely ignored by the market.
Aug 2024: SMCI delays its annual report, and short-seller allegations trigger a sharp stock decline, bringing renewed attention to governance and related-party concerns that had been flagged years earlier.
Resignations and Dismissals
What this captures
This category tracks leadership turnover that affects governance and financial reporting oversight. It focuses on disclosed departures, resignations, terminations, and appointments involving senior executives – particularly the CEO and finance leadership (CFO, CAO, controller) – as well as key board oversight roles and changes in the external auditor.
The goal is to identify leadership transitions that could affect the environment in which financial reporting and disclosure decisions are made.
Why this matters
Leadership turnover can be an important signal about what is happening inside a company. Changes involving finance leadership, audit oversight, or auditors themselves may reflect disputes over accounting, internal control issues, or broader governance problems. Even when reasons are not disclosed, abrupt departures, interim leadership, or clusters of turnover can disrupt oversight and increase the risk of reporting problems during periods of transition.
Example
Under Armour (2016–2020)
February 2016: Longtime CFO Brad Dickerson steps down after eight years in the role. Chip Molloy is appointed CFO.
Early 2017: Chip Molloy departs after roughly one year as CFO, an unusually short tenure for the company’s finance chief. David Bergman takes over the role.
2017 – 2018: Under Armour reports slowing growth and rising inventory levels as competition intensifies and its rapid-expansion strategy begins to come under pressure.
November 2019: The company confirms investigations by the U.S. Securities and Exchange Commission and the U.S. Department of Justice into whether sales were shifted between quarters to meet internal revenue targets.
May 2021: Under Armour agrees to pay a $9 million settlement with the SEC related to disclosure violations involving revenue timing practices.
Internal Controls
What this captures
The Internal Controls rating evaluates the reliability of a company’s financial reporting environment. The Co-Analyst looks for signals in the company’s disclosures that indicate whether the systems and processes used to produce the financial statements are functioning effectively.
Public companies rely on internal controls – such as review procedures, accounting policies, system safeguards, and oversight processes – to ensure financial information is accurate and complete. When companies disclose weaknesses in these controls, it suggests that the safeguards designed to prevent or detect reporting errors may not be fully effective.
Typical signals:
- Disclosure of material weaknesses or significant deficiencies in internal control over financial reporting
- Statements that management or auditors cannot conclude that controls are effective
- Restatements tied to control failures
- Delays in financial filings linked to control remediation efforts
- Descriptions of insufficient accounting personnel, systems, or oversight processes
Why this matters
Internal control quality is one of the clearest indicators of the reliability of a company’s financial reporting. When those controls are ineffective, the risk of misstatements, whether due to error or manipulation, increases.
Material weaknesses in ICOFR often arise when companies lack sufficient accounting personnel, robust financial processes, or effective oversight. In other cases, they reflect broader breakdowns in management discipline or governance.
Companies often disclose a material weakness when external auditors identify errors that management did not catch themselves. Even if those errors are corrected before financial statements are released, this indicates that internal controls failed to operate effectively. Public companies shouldn’t be relying on auditors to find their mistakes. Audits are inherently limited in scope and cannot test every transaction or control. If issues are surfaced in one area only because of an external review, it raises the risk that other errors may remain undetected.
For investors and analysts, disclosures of internal control weaknesses can serve as an early signal that the company’s financial reporting environment may be fragile and that additional reporting or governance problems may emerge over time. For a deeper discussion of how to interpret these signals in stock research, see our post on interpreting internal control weaknesses (ICOFR) in stock research.
Our internal research shows that large cap companies that report a material weakness are 2.23 times as likely to see a substantial, persistent price decline in the next 6 months.
Example
Luckin Coffee (2019–2020)
2019: In its IPO filing, Luckin disclosed material weaknesses in internal control over financial reporting, including insufficient accounting personnel and inadequate reporting processes.
January 2020: Short seller Muddy Waters Research published a report alleging that the company had inflated sales.
April 2020: Luckin announced that an internal investigation found fabricated sales transactions totaling roughly $300 million.
April 2020: The stock fell more than 80% after the company admitted fabricated sales.
June 2020: Nasdaq delisted the company.
December 2020: The company agreed to pay a $180 million penalty to the U.S. Securities and Exchange Commission to settle accounting fraud charges.
Legal and Regulatory Exposure
What this captures
The Legal and Regulatory rating assesses whether a company’s disclosures indicate meaningful legal or regulatory conflict. It focuses on concrete events such as government investigations, enforcement actions, significant litigation, settlements, or allegations of misconduct involving the company or its leadership. The goal is to identify situations where regulators, prosecutors, or civil litigants are actively scrutinizing the company’s conduct.
This category is not about routine litigation or ordinary regulatory exposure. Instead, it looks for evidence of rule-breaking, legal disputes, or regulatory violations that may signal deeper governance, compliance, or operational problems.
Typical signals:
- Disclosure of government investigations, regulatory inquiries, or subpoenas
- Enforcement actions, penalties, or settlement agreements with regulators
- Material litigation, class actions, or legal disputes involving the company or its leadership
- Allegations of misconduct involving customers, contracts, or regulatory compliance
- Repeated or escalating scrutiny across multiple regulators, agencies, or legal proceedings
- Disclosures indicating ongoing monitoring agreements, consent orders, or regulatory oversight
Why this matters
Legal and regulatory scrutiny often signals underlying compliance or governance weaknesses, and these issues rarely occur in isolation. In many cases, they recur over time, reflecting gaps in controls, culture, or oversight that haven’t been fully addressed.
This pattern of recidivism matters. Companies that have faced investigations, litigation, or enforcement actions are often more likely to face them again. Misconduct involving customers, contracts, or regulatory compliance can also indicate a higher risk of misleading investors.
These risks are often underestimated by the market. Individual cases are frequently treated as one-offs, but repeated issues can point to something more structural, raising the likelihood of future penalties, disruption, and reputational damage that may not be fully priced in.
Examples
Wells Fargo (2013 – 2022)
2013 – 2015: Reports emerge that employees opened unauthorized customer accounts to meet aggressive internal sales targets, prompting investigations by regulators.
September 2016: Wells Fargo agrees to pay $185 million in penalties to regulators including the Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency for opening millions of unauthorized accounts.
2017 – 2018: Additional investigations expand into other areas of the bank’s operations, including auto lending and mortgage servicing practices, as regulators raise broader concerns about governance and risk controls.
February 2018: The Federal Reserve imposes an unprecedented asset cap restricting Wells Fargo’s growth until the bank improves its risk management and governance practices.
December 2022: The Consumer Financial Protection Bureau orders Wells Fargo to pay $3.7 billion in penalties and consumer remediation related to widespread misconduct across multiple consumer banking products.
Governance
What this captures
This category looks for disclosure that suggests weak discipline or accountability at the top of the organization. It focuses on signals that leadership may be insulated from oversight, able to extract personal benefits, or operating with limited independent checks. Such conditions raise the risk of weak controls or tolerance for misrepresentation.
Common governance signals include meaningful executive perks or personal use of company resources, auditor or audit oversight disruptions, gaps in board independence or audit committee effectiveness, and control or entrenchment mechanisms that materially limit accountability, especially when combined with weak oversight.
Typical signals:
- Board waivers of conflict-of-interest policies or ethics rules
- Executive perks or personal use of company assets beyond typical practice
- Weaknesses in board independence or audit committee oversight
- Governance structures that concentrate control with insiders
- Oversight disruptions involving auditors, board committees, or governance processes
Why this matters
Governance is the “operating system” that determines whether problems get surfaced and corrected – or hidden and rationalized. When oversight is weak or insiders are entrenched, management can face fewer consequences for aggressive reporting, rule-bending, or self-dealing. That can show up later as control failures, unreliable disclosure, regulatory conflict, or value leakage to insiders.
Strong governance doesn’t guarantee good outcomes, but weak governance increases the odds that bad news travels slowly – and that small issues become larger ones before investors see them.
Example
WeWork (2017 – 2019)
2017 – 2019: Office-sharing company WeWork expands rapidly under founder and CEO Adam Neumann, raising billions from private investors and pursuing aggressive global growth.
2019: As the company prepares to go public, disclosures reveal a multi-class share structure that gives Neumann voting control far exceeding his economic ownership, allowing him to retain effective control over major corporate decisions.
August 2019: The company’s parent, The We Company, files for an initial public offering. The IPO prospectus draws investor attention to governance features including concentrated founder voting power, related-party transactions involving Neumann, and governance arrangements that limit independent oversight.
September 2019: Investor concerns about governance, losses, and accountability intensify following the IPO filing, and the company withdraws the planned offering.
September 2019: Neumann steps down as CEO as investors push for leadership and governance changes.
Strategic Complexity
What this captures
This category looks at whether a company’s story is being shaped by structural change rather than straightforward business execution. It focuses on acquisitions, divestitures, restructurings, segment changes, and other shifts that alter what business the company is in, how it is organized, or how its performance is reported.
The point is not whether the strategy is good or bad. It is whether the company has become complex, deal-driven, or hard to read in a way that makes underlying performance less transparent.
Typical signals:
- Rapid pace of acquisitions, divestitures, or restructurings
- Frequent segment reorganizations or reporting structure changes
- Growth driven largely by transactions rather than organic performance
- Repeated integration programs, restructuring charges, or impairments
- Business models that become increasingly complex or difficult to track over time
Why this matters
When a company is constantly buying, selling, reorganizing, or redefining parts of the business, it becomes harder for investors to tell what is actually driving results. Reported growth may reflect transactions rather than organic performance, while repeated restructurings or impairments can make it harder to separate temporary noise from durable economics.
This kind of complexity does not necessarily mean something is wrong. But it can create an environment where weak businesses stay hidden longer, loss recognition gets delayed, or management has more room to manage the narrative around performance.
Example
Teva Pharmaceutical Industries (2015 – 2018)
2015: Teva announces the acquisition of the generics business of Allergan (Actavis Generics) in a roughly $40 billion deal that dramatically increases its scale and leverage.
2016: The acquisition closes. Teva becomes the world’s largest generic drug manufacturer but takes on a large debt burden.
2017: As the generics market weakens, Teva begins restructuring operations and selling assets while recording multi-billion-dollar impairment charges tied to the acquired business.
2017–2018: Investors reassess the sustainability of the strategy as earnings expectations fall and leverage remains high. The stock declines sharply.
Interested in exploring the Hudson Labs forensic risk score and red flags?
👉 Book a demo to learn about the institutional tier features.
